Why Do We Still Not Have Cardioprotective Drugs?-Reference-Cited by-同舟云学术

Why Do We Still Not Have Cardioprotective Drugs?

Published:2009 Issue:7 Volume:73 Page:1171-1177
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Downey James M.¹,Cohen Michael V.¹²

Affiliation:

1. Department of Physiology, University of South Alabama, College of Medicine

2. Department of Medicine, University of South Alabama, College of Medicine

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://www.jstage.jst.go.jp/article/circj/73/7/73_CJ-09-0338/_pdf

Reference54 articles.

1. 1. Braunwald E. Reduction of myocardial-infarct size [Editorial]. N Engl J Med 1974; 291: 525-526.

2. 2. Maroko PR, Kjekshus JK, Sobel BE, Watanabe T, Covell JW, Ross J Jr, et al. Factors influencing infarct size following experimental coronary artery occlusions. Circulation 1971; 43: 67-82.

3. 3. Reimer KA, Rasmussen MM, Jennings RB. Reduction by propranolol of myocardial necrosis following temporary coronary artery occlusion in dogs. Circ Res 1973; 33: 353-363.

4. 4. Reimer KA, Jennings RB. Can we really quantitate myocardial cell injury? In: Hearse DJ, Yellon DM, editors.Therapeutic approaches to myocardial infarct size limitation. Raven Press: New York; 1984; 163-184.

5. 5. Tissier R, Cohen MV, Downey JM. Protecting the acutely ischemic myocardium beyond reperfusion therapies: Are we any closer to realizing the dream of infarct size elimination? Arch Mal Coeur Vaiss 2007; 100: 794-802.

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond Erectile Dysfunction: cGMP-Specific Phosphodiesterase 5 Inhibitors for Other Clinical Disorders;Annual Review of Pharmacology and Toxicology;2023-01-20

2. Nitric Oxide-cGMP-PKG Signaling in the Cardioprotective Effects of Phosphodiesterase 5 Inhibitors;Nitric Oxide: From Research to Therapeutics;2023

3. SUR2A as a base for cardioprotective therapeutic strategies;Molecular Biology Reports;2022-03-17

4. Role of platelet rich plasma mediated repair and regeneration of cell in early stage of cardiac injury;Regenerative Therapy;2022-03

5. Reversing mitochondrial defects in aged hearts: role of mitochondrial calpain activation;American Journal of Physiology-Cell Physiology;2022-02-01